TMCnet News
Global Obesity Report 2017: Treatment Rate for Top Seven Pharmaceutical Markets - Research and MarketsResearch and Markets has announced the addition of the "Global Obesity Epidemiology and Patient Flow Analysis - 2017" report to their offering. The results of the Obesity patients study are announced in this new report. The report provides insights into Obesity epidemiology, Obesity diagnosed patients, and Obesity treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Obesity derived from epidemiological analysis, percentage of patients diagnosed with Obesity, and percentage of patients treated with a therapy. The study helps executives estimate Obesity market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presentedin this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Obesity prevalence, Obesity diagnosis rate, and Obesity treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. Key Features of the Report:
Key Topics Covered: 1. Obesity: Disease Definition 2. Global Obesity Patient Flow 3. Obesity Patient Flow in the US 4. Obesity Patient Flow in Europe 5. Obesity Patient Flow in Germany 6. Obesity Patient Flow in France 7. Obesity Patient Flow in Spain 8. Obesity Patient Flow in Italy 9. Obesity Patient Flow in UK 10. Obesity Patient Flow in Japan 11. Research Methodology For more information about this report visit http://www.researchandmarkets.com/research/g4xtv5/global_obesity View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005298/en/ |
